The Korean Journal of Clinical Laboratory Science : eISSN 2288-1662 / pISSN 1738-3544

Table. 7.

Table. 7.

Distribution of resistant, intermediate and susceptible isolates in probiotics isolated from Kimchi to antimicrobial agents

Antimicrobials No. of isolates (%)

Resistant Intermediate Susceptible
Ampicillin 16 (11.4) 11 (7.9) 113 (80.7)
Streptomycin 117 (83.6) 5 (3.6) 18 (12.9)
Sulfamethoxazole/Trimethoprim 83 (59.3) 12 (8.6) 45 (32.1)
Vancomycin 103 (73.6) 2 (1.4) 35 (25.0)
Gentamicin 106 (75.7) 0 34 (24.3)
Tetracycline 14 (10.0) 8 (5.7) 118 (84.3)
Oxacillin 98 (70.0) 18 (12.9) 24 (17.1)
Norfloxacin 101 (72.1) 24 (17.1) 15 (10.7)
Nalidixic acid 138 (98.6) 1 (0.7) 1 (0.7)
Erythromycin 45 (32.1) 0 95 (67.9)
Cephalothin 27 (19.3) 34 (24.3) 79 (56.4)
Clindamycin 37 (26.4) 28 (20.0) 75 (53.6)
Rifampicin 32 (22.9) 24 (17.1) 84 (60.0)
Cefotetan 136 (97.1) 1 (0.7) 3 (2.1)
Chloramphenicol 14 (10.0) 1 (0.7) 125 (89.3)
Penicillin 14 (10.0) 57 (40.7) 69 (49.3)
Imipenem 15 (10.7) 0 125 (89.3)
Ciprofloxacin 95 (67.9) 22 (15.7) 23 (16.4)
Korean J Clin Lab Sci 2019;51:294-300 https://doi.org/10.15324/kjcls.2019.51.3.294
© 2019 Korean J Clin Lab Sci